Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Apr;40(1):193–196.

Cimetidine does not accelerate skin graft rejection in mice.

H P Festen, J H Berden, R A Koene
PMCID: PMC1536940  PMID: 6993076

Abstract

The influence of cimetidine on skin graft rejection was studied in a well defined transplantation model of inbred mice. Four allogeneic transplantation combinations with increasing antigenic disparity and one xenograft combination were studied. Cimetidine (25 mg/kg body weight) was administered intraperitoneally at 8-hr intervals until rejection occurred. No differences in graft survival were observed between cimetidine-treated groups and saline-treated controls in any of the combinations studied.

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avella J., Madsen J. E., Binder H. J., Askenase P. W. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet. 1978 Mar 25;1(8065):624–626. doi: 10.1016/s0140-6736(78)91134-0. [DOI] [PubMed] [Google Scholar]
  2. Berden J. H., Gerlag P. G., Hagemann J. F., Koene R. A. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility. Transplantation. 1977 Sep;24(3):175–182. doi: 10.1097/00007890-197709000-00002. [DOI] [PubMed] [Google Scholar]
  3. Corry R. J., Winn H. J., Russell P. S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973 Oct;16(4):343–350. doi: 10.1097/00007890-197310000-00010. [DOI] [PubMed] [Google Scholar]
  4. Gerlag P. G., Capel P. J., Berden J. H., Koene R. A. Antibody response and skin graft rejection in the nude mouse. Transplant Proc. 1977 Mar;9(1):1179–1182. [PubMed] [Google Scholar]
  5. Graff R. J., Bailey D. W. The non-H-2 histocompatibility loci and their antigens. Transplant Rev. 1973;15:26–49. doi: 10.1111/j.1600-065x.1973.tb00109.x. [DOI] [PubMed] [Google Scholar]
  6. Isakov N., Yankelevich B., Segal S., Feldman M. Differential immunogenic expression of an H-2-linked histocompatibility antigen on different tissues. Differences in survival between heart, thyroid, and skin allografts. Transplantation. 1979 Jul;28(1):31–35. doi: 10.1097/00007890-197907000-00007. [DOI] [PubMed] [Google Scholar]
  7. Jones R. H., Rudge C. J., Bewick M., Parsons V., Weston M. J. Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation. Br Med J. 1978 Feb 18;1(6110):398–400. doi: 10.1136/bmj.1.6110.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McGregor C. G., Cochran A. J., Ogg L. J., Gray G. R., Smith I. S., Gillespie G., Forrester J. Immunological and other laboratory studies of patients receiving short-term cimetidine therapy. Lancet. 1977 Jan 15;1(8003):122–123. doi: 10.1016/s0140-6736(77)91709-3. [DOI] [PubMed] [Google Scholar]
  9. Pennycuik P. R. Unresponsiveness of nude mice to skin allografts. Transplantation. 1971 Apr;11(4):417–418. doi: 10.1097/00007890-197104000-00012. [DOI] [PubMed] [Google Scholar]
  10. Plaut M., Lichtenstein L. M., Gillespie E., Henney C. S. Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J Immunol. 1973 Aug;111(2):389–394. [PubMed] [Google Scholar]
  11. Plaut M., Lichtenstein L. M., Henney C. S. Properties of a subpopulation of T cells bearing histamine receptors. J Clin Invest. 1975 Apr;55(4):856–874. doi: 10.1172/JCI107997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Primack W. A. Cimetidine and renal-allograft rejection. Lancet. 1978 Apr 15;1(8068):824–825. doi: 10.1016/s0140-6736(78)93025-8. [DOI] [PubMed] [Google Scholar]
  13. Rocklin R. E. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest. 1976 Apr;57(4):1051–1058. doi: 10.1172/JCI108347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Russell P. S., Chase C. M., Colvin R. B., Plate J. M. Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med. 1978 May 1;147(5):1449–1468. doi: 10.1084/jem.147.5.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rygaard J. Skin grafts in nude mice. 1. Allografts in nude mice of three genetic backgrounds (BALB-c, C3H, C57-BL). Acta Pathol Microbiol Scand A. 1974 Jan;82(1):80–92. [PubMed] [Google Scholar]
  16. Wang S. R., Zweiman B. Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol. 1978 Mar 1;36(1):28–36. doi: 10.1016/0008-8749(78)90247-2. [DOI] [PubMed] [Google Scholar]
  17. Zammit M., Toledo-Pereyra L. H. Increased rejection after cimetidine treatment in kidney transplants. Transplantation. 1979 May;27(5):358–359. doi: 10.1097/00007890-197905000-00017. [DOI] [PubMed] [Google Scholar]
  18. de Pauw B. E., Lamers C. B., Wagener D. J., Festen H. P. Immunological studies after long-term H2-receptor-antagonist therapy. Lancet. 1977 Sep 17;2(8038):616–616. doi: 10.1016/s0140-6736(77)91472-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES